Skip to main content

GOLDMAN SACHS GROUP INC

Position in GALT — Galectin Therapeutics Inc

CIK 886982 NEW YORK, NY

Position in GALT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$515,415
-$762,657 QoQ
Shares Held
184,737
-39.9% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. GALT ranks #287 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GALT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $515,415 184,737
2025-12-31 $1,278,072 307,229
2025-09-30 $93,339 22,014
2025-06-30 $55,427 26,269
2025-03-31 $13,052 10,699
2024-12-31 $61,302 47,521
2024-09-30 $90,838 33,032
2024-06-30 $50,992 22,563
2022-06-30 $24,128 18,419
2022-03-31 $17,323 10,760
2021-12-31 $23,372 11,291
2021-09-30 $57,101 14,717
2021-06-30 $58,160 18,175
2021-03-31 $45,162 20,812
2020-12-31 $51,880 23,161
2020-09-30 $55,146 20,654
2020-06-30 $63,629 20,794
2020-03-31 $32,683 16,675